Chimerix to Present at JonesTrading Virtual Precision Medicine Symposium
(NasdaqGM:CMRX), DURHAM, N.C., Jan. 29, 2025 (GLOBE NEWSWIRE) — Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that meaningfully improve and extend the lives of patients facing deadly diseases, today announced that Mike Andriole, Chief Executive Officer, and Tom Riga, Chief Operating and Commercial Officer, will participate in a fireside […]